HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Enviomycin

Cyclic basic peptide related to VIOMYCIN. It is isolated from an induced mutant of Streptomyces griseoverticillatus var. tuberacticus and acts as an antitubercular agent with less ototoxicity than tuberactinomycin.
Also Known As:
Tuberactinomycin-N; Tuberactinomycin N; Viomycin, 1-((3R,4R)-4-hydroxy-3,6-diaminohexanoic acid)-6-(L-2-(2-amino-1,4,5,6-tetrahydro-4-pyrimidinyl)glycine)-, (R)-
Networked: 18 relevant articles (1 outcomes, 7 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Nakajima, Yutsuki: 1 article (11/2007)
2. Yoshiyama, Takashi: 1 article (11/2007)
3. Ogata, Hideo: 1 article (11/2007)
4. Ueyama, Masako: 1 article (11/2007)
5. Wada, Masako: 1 article (11/2007)
6. Tadokoro, Eiji: 1 article (11/2007)
7. Kokutoh, Hiroyuki: 1 article (11/2007)
8. Okumura, Masao: 1 article (11/2007)
9. Kubota, Motoko: 1 article (11/2007)

Related Diseases

1. Lung Diseases (Lung Disease)
2. Pulmonary Tuberculosis
3. Tuberculosis (Tuberculoses)
4. Hypersensitivity (Allergy)

Related Drugs and Biologics

1. Streptomycin (Streptomycin Sulfate)
2. Rifampin (Rifampicin)
3. Isoniazid (Ftivazide)
4. Viomycin (Viocin)
5. Kanamycin
6. Enviomycin
7. Ethambutol (Myambutol)

Related Therapies and Procedures

1. Retreatment